Clinical trial
Calcium Channel Blockers in Nitric Oxide Non-responder Pulmonary Arterial Hypertension.
NCT01645826 is registered in ClinicalTrials.gov with University of South Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Calcium Channel Blockers in Nitric Oxide Non-responder Pulmonary Arterial Hypertension.
- Lead sponsor
- University of South Florida
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- July 31, 2012
- Completion date
- September 30, 2014
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
familial primary pulmonary hypertension, idiopathic pulmonary arterial hypertension, primary pulmonary hypertension, pulmonary arterial hypertension